CNTG Centogene NV Gross Profit Margin

CNTG (CENTOGENE N.V.) - company brandmark

Centogene N.V. diagnostic efficiency is based on the scale of its biobank and partnerships with pharma behemoths, while cash flow stability relies on the volume of research contracts. The current gross margin demonstrates operational efficiency, where the value of 0.00 corresponds to the current metric. Independence from macroeconomics and the demand for innovation make this sector a reliable defensive asset.

CNTG Centogene NV: Gross Margin in the range 07/04/2022 - 08/17/2024

Financial and market metric breakdowns for CENTOGENE (CNTG)

- share price and expert price forecast:
- market capitalization data:
Summary company analysis:CENTOGENE (CNTG)
Brand item of centogene.com

The long-term sustainability of Centogene N.V. (CNTG) is determined by the efficiency of managing direct diagnostic costs. Gross margin measures the profit share of each unit of revenue after deducting production expenses, reflecting the fundamental profitability of operations. An analysis of the gross margin after cost of goods sold demonstrates how sequencing robotics and AI analysis reduce the impact of human error, optimizing test costs and strengthening the business model.